Pfizer and BioNTech's Coronavirus Vaccine Remains Effective for at Least 6 Months
People who've been inoculated with the BNT162b2 coronavirus vaccine from Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) can look forward to its protection lasting for a minimum of six months.
On Thursday, the two companies released a top-line analysis from 927 confirmed cases of COVID-19, the disease triggered by the coronavirus. This indicates that the jab was over 91% effective against the affliction -- an extremely high number for any vaccine. Very encouragingly, this was tracked from one week to six months after the recipients received their second shot of the two-shot BNT162b2.
Image source: Getty Images.
Source Fool.com
